Search | Page 10 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

    ... chemotherapy will improve the response to a stem cell transplant . The safety of this treatment will also be studied. ... Hodgkin disease, or MM, after they have received an allogeneic stem cell transplant . The chemotherapy participant will be ...

    Clinical Trial last updated 06/06/2016 - 12:41pm.

  2. Bone Marrow and Stem Cell Transplantation

    ... thinks you may be a candidate for a bone marrow or stem cell transplant , you should start looking for a donor now. It can take ... option for patients with bone marrow failure diseases. Allogeneic transplants use cells from a healthy donor. The donor's tissue type ...

    Page last updated 09/30/2014 - 11:47am.

  3. Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    ... trial studies how well giving donor T cells after donor stem cell transplant works in treating patients with hematologic ... Intervention:  Biological: therapeutic allogeneic lymphocytes Given IV Other Name: ALLOLYMPH Other: laboratory ...

    Clinical Trial last updated 05/03/2016 - 11:17am.

  4. Overview of stem cell transplantation for aplastic anemia

    ... PubMed Abstract:  Allogeneic transplantation for aplastic anemia ... cyclosporine (CsA), or an allogeneic hematopoietic stem cell transplantation (Allo-HSCT).  An Allo-HSCT is a type of bone ...

    Research Review last updated 05/02/2016 - 9:31am.

  5. Lenalidomide After Allo-Hematopoietic Cell Transplant (HCT) in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndromes (MDS) Subjects With Minimal Residual Disease (UF-BMT-MRD-101)

    ... MDS who have a small amount of detectable disease after allogeneic stem cell transplant . ...

    Clinical Trial last updated 04/29/2016 - 2:38pm.

  6. Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelopdysplastic Syndrome

    ... and about 50 percent of responders will relapse. Allogeneic bone marrow transplantation from either HLA -matched sibling ... disorders are not suitable candidates for hematopoietic stem cell transplantation (HSCT) due to advanced age or lack of a histocompatible ...

    Clinical Trial last updated 04/25/2016 - 2:18pm.

  7. Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

    ... disease (GVHD) after nonmyeloablative peripheral blood stem cell (PBSC) transplant in patients with hematological malignancies. Giving ... IV Other Names: Cellcept MMF Procedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation Undergo nonmyeloablative ...

    Clinical Trial last updated 05/03/2016 - 9:44am.

  8. Pregnancy in Bone Marrow Failure Disease

    ... to people without them. But in people who have had an allogeneic stem cell/ bone marrow transplant , the immunosuppressive medications may ...

    Interview last updated 01/13/2017 - 9:28am.

  9. Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    ... that of patients undergoing haploidentical RIC hematopoietic stem cell transplantation (HSCT) as reported in the literature and as observed ... Transplantation Undergo PBSC transplant Procedure: Allogeneic Hematopoietic Stem Cell Transplantation Undergo PBSC ...

    Clinical Trial last updated 04/27/2016 - 1:37pm.

  10. Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    ... This phase II trial studies how well donor peripheral blood stem cell (PBSC) transplant works in treating patients with hematologic ... who may benefit from tandem autologous-nonmyeloablative allogeneic transplant Left ventricular ejection fraction at rest must be >= ...

    Clinical Trial last updated 04/29/2016 - 3:26pm.